ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

Upton Promises “Minimal Disruption” As Result of Changes; Centers Program Probably To Move

January 20, 1978

In Brief: Adjuvant Chemotherapy Standard Practice For Breast Cancer At Milan, Bonadonna Says

May 7, 1976

Funding Opportunities

February 7, 2003

McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.

June 2, 2000